Portage Biotech Inc (PRTG)

$0.28

+0.04

(+16.67%)

Market is closed - opens 7 PM, 20 Jun 2024

Insights on Portage Biotech Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 74.6% return, outperforming this stock by 167.2%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 242.2% return, outperforming this stock by 341.5%

Performance

  • $0.23
    $0.32
    $0.28
    downward going graph

    18.32%

    Downside

    Day's Volatility :28.08%

    Upside

    11.95%

    downward going graph
  • $0.20
    $3.95
    $0.28
    downward going graph

    28.61%

    Downside

    52 Weeks Volatility :94.94%

    Upside

    92.91%

    downward going graph

Returns

PeriodPortage Biotech IncSector (Health Care)Index (Russel 2000)
3 Months
-49.09%
0.1%
0.0%
6 Months
-77.6%
8.3%
0.0%
1 Year
-92.39%
10.4%
0.0%
3 Years
-99.29%
17.9%
-20.9%

Highlights

Market Capitalization
4.8M
Book Value
$1.62
Earnings Per Share (EPS)
-8.52
Wall Street Target Price
7.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-9.13%
Return On Equity TTM
-145.19%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-18.9M
Diluted Eps TTM
-8.52
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.65
EPS Estimate Next Year
-0.52
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 6 Wall street analysts offering stock ratings for Portage Biotech Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
3
3
3
Sell
3
3
3

Analyst Forecast

What analysts predicted

Upside of 2400.0%

Current $0.28
Target $7.00

Technicals Summary

Sell

Neutral

Buy

Portage Biotech Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Portage Biotech Inc
Portage Biotech Inc
1.6%
-77.6%
-92.39%
-99.29%
-99.23%
Moderna, Inc.
Moderna, Inc.
-5.49%
49.59%
7.28%
-36.0%
759.81%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
5.25%
22.48%
33.01%
94.49%
234.3%
Novo Nordisk A/s
Novo Nordisk A/s
5.94%
40.81%
74.18%
240.71%
437.2%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.8%
15.91%
36.36%
148.95%
157.1%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Portage Biotech Inc
Portage Biotech Inc
NA
NA
NA
-0.65
-1.45
-0.09
NA
1.62
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.72
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
30.58
30.58
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
49.48
49.48
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.16
31.16
0.53
17.09
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Portage Biotech Inc
Portage Biotech Inc
Sell
$4.8M
-99.23%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$53.7B
759.81%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$114.2B
234.3%
30.58
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$636.1B
437.2%
49.48
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$124.1B
157.1%
31.16
39.46%

Institutional Holdings

  • Armistice Capital, LLC

    8.42%
  • Lakeview Capital Partners, LLC

    1.08%
  • PEAK6 INVESTMENTS LP

    0.28%
  • Millennium Management LLC

    0.17%
  • Renaissance Technologies Corp

    0.16%
  • BlackRock Inc

    0.16%

Company Information

portage biotech inc is a company based out of canada.

Organization
Portage Biotech Inc
Employees
7
CEO
Dr. Ian B. Walters M.B.A., M.D.
Industry
Healthcare

FAQs